Delivery Order SPE2DR25D2203-SPE2DR26FD2SN
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $12,247.59 to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 10 mg/0.5 ml pens on December 12, 2025, with final completion scheduled for December 15, 2025. This firm fixed price delivery order was competitively awarded without set-aside restrictions and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The order represents a routine pharmaceutical procurement supporting federal healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $5,701.05 to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 15 mg/0.5 mL pens on November 14, 2025, with completion expected by November 17, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order transaction under the...
- The Defense Logistics Agency awarded a delivery order valued at $6,165.74 to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 5 mg/0.5 mL pens on November 20, 2025, with completion scheduled for November 21, 2025. This delivery order is issued under a firm fixed-price contract structure without any set-aside designation, indicating competitive procurement. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a $17,564.19 delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 10 mg/0.5 mL pens on July 21, 2025, with an ultimate completion date of July 22, 2025. This competitively awarded, firm fixed-price contract includes no set-aside designation and specifies performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a small-value transaction within the company's...
- The Defense Logistics Agency awarded a $32,717.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 7.5 mg/0.5 mL pens on September 8, 2025, with an ultimate completion date of September 9, 2025. This non-competitive delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99 million and extending through December 2026. The contract was fulfilled from the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Zepbound (semaglutide) 5 mg/0.5 mL pens with a contract ceiling value of $5,984.68. This is a firm fixed-price delivery order with an ultimate completion date of December 4, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation, allowing AmerisourceBergen to...
- The Defense Logistics Agency awarded a delivery order valued at $8,463.35 to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 5 mg/0.5 mL pen injections on December 3, 2025, with a completion date of December 4, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of pharmaceutical supply services through AmerisourceBergen's larger contract vehicle. The product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $14,343.19 to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 10 mg/0.5 mL pen injectors on July 22, 2025, with an ultimate completion date of July 23, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a $16,297.57 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Zepbound (semaglutide) 10 mg/0.5 mL pens. The contract represents a firm fixed-price delivery order with an ultimate completion date of August 14, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's demonstrated...
- The Defense Logistics Agency awarded a $13,067.60 delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Zepbound (semaglutide) 10 mg/0.5 mL pens under a firm fixed price contract. The order is scheduled for completion by August 8, 2025, with performance to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation and represents a relatively small-value transaction...
- SPE2DR25D2203Indefinite Delivery Contract
- SPE2DR25D2203-SPE2DR26FD2SNDelivery Order
The Defense Logistics Agency awarded a $17,804.99 delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 5 mg/0.5 mL pens on December 12, 2025, with an ultimate completion date of December 15, 2025. This non-set-aside, firm fixed-price delivery order represents a competitive award under the company's broader pharmaceutical supply relationship with the federal government. The award was placed to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as the primary pharmaceutical supply vehicle for military healthcare systems. As a major pharmaceutical distributor, AmerisourceBergen maintains an extensive portfolio of federal contracts supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. The company's firm fixed-price delivery orders typically range from small-value transactions to substantial orders exceeding $45,000, demonstrating its capability to fulfill diverse federal medical supply requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.8k | 12/11/25 |